MedEquities Realty Trust Inc (MRT) Director Bluemountain Capital Managemen Sells 12,816 Shares of Stock

Share on StockTwits

MedEquities Realty Trust Inc (NYSE:MRT) Director Bluemountain Capital Managemen sold 12,816 shares of the stock in a transaction that occurred on Wednesday, October 10th. The shares were sold at an average price of $9.16, for a total value of $117,394.56. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Bluemountain Capital Managemen also recently made the following trade(s):

  • On Friday, October 5th, Bluemountain Capital Managemen sold 3,955 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $9.13, for a total value of $36,109.15.
  • On Monday, October 8th, Bluemountain Capital Managemen sold 18,052 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $9.20, for a total value of $166,078.40.

MRT traded down $0.04 during trading hours on Friday, hitting $8.79. 151,484 shares of the stock were exchanged, compared to its average volume of 153,182. MedEquities Realty Trust Inc has a 12 month low of $8.64 and a 12 month high of $12.04. The stock has a market capitalization of $309.70 million, a PE ratio of 7.71 and a beta of -0.07.

MedEquities Realty Trust (NYSE:MRT) last announced its quarterly earnings data on Wednesday, August 8th. The financial services provider reported $0.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.30 by ($0.20). MedEquities Realty Trust had a return on equity of 5.73% and a net margin of 30.84%. The firm had revenue of $17.56 million for the quarter, compared to the consensus estimate of $17.03 million. Sell-side analysts predict that MedEquities Realty Trust Inc will post 1.08 EPS for the current year.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Raymond James Financial Services Advisors Inc. lifted its stake in MedEquities Realty Trust by 18.8% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 31,018 shares of the financial services provider’s stock worth $342,000 after purchasing an additional 4,913 shares during the last quarter. Martingale Asset Management L P lifted its stake in MedEquities Realty Trust by 2.0% during the second quarter. Martingale Asset Management L P now owns 258,242 shares of the financial services provider’s stock worth $2,846,000 after purchasing an additional 5,100 shares during the last quarter. Schwab Charles Investment Management Inc. increased its position in MedEquities Realty Trust by 0.7% in the second quarter. Schwab Charles Investment Management Inc. now owns 764,932 shares of the financial services provider’s stock worth $8,430,000 after buying an additional 5,106 shares during the period. Millennium Management LLC increased its position in MedEquities Realty Trust by 3.5% in the second quarter. Millennium Management LLC now owns 184,782 shares of the financial services provider’s stock worth $2,036,000 after buying an additional 6,188 shares during the period. Finally, Northern Trust Corp increased its position in MedEquities Realty Trust by 2.4% in the second quarter. Northern Trust Corp now owns 323,411 shares of the financial services provider’s stock worth $3,564,000 after buying an additional 7,661 shares during the period. Hedge funds and other institutional investors own 90.80% of the company’s stock.

Several equities analysts have recently commented on MRT shares. B. Riley set a $12.00 target price on MedEquities Realty Trust and gave the company a “buy” rating in a research note on Thursday, August 9th. Zacks Investment Research upgraded MedEquities Realty Trust from a “hold” rating to a “buy” rating and set a $13.00 target price for the company in a research note on Wednesday, July 25th. ValuEngine upgraded MedEquities Realty Trust from a “sell” rating to a “hold” rating in a research note on Tuesday, July 10th. Royal Bank of Canada set a $10.00 price objective on MedEquities Realty Trust and gave the stock a “hold” rating in a research note on Sunday, August 12th. Finally, KeyCorp cut MedEquities Realty Trust from an “overweight” rating to a “hold” rating and set a $12.00 price objective on the stock. in a research note on Wednesday, August 8th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $11.56.

About MedEquities Realty Trust

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Recommended Story: What is the 52-week high/low?

Insider Buying and Selling by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply